Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial

[1]  R. Ouvrier,et al.  Outcome of Early Juvenile Onset Metachromatic Leukodystrophy After Unrelated Cord Blood Transplantation: A Case Series and Review of the Literature , 2016, Journal of child neurology.

[2]  G. Raymond,et al.  Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report , 2015, Orphanet Journal of Rare Diseases.

[3]  A. Biffi,et al.  Hematopoietic stem cell transplantation for metachromatic leukodystrophy , 2015 .

[4]  S. Groeschel,et al.  Language and cognition in children with metachromatic leukodystrophy: onset and natural course in a nationwide cohort , 2014, Orphanet Journal of Rare Diseases.

[5]  F. Eichler,et al.  Hematopoietic Stem Cell Transplantation in the Leukodystrophies: A Systematic Review of the Literature , 2014, Neuropediatrics.

[6]  C. von Kalle,et al.  Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy , 2013, Science.

[7]  F. Barkhof,et al.  Improvement of white matter changes on neuroimaging modalities after stem cell transplant in metachromatic leukodystrophy. , 2013, JAMA neurology.

[8]  M. Poe,et al.  Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  T. Nägele,et al.  Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort , 2013, Bone Marrow Transplantation.

[10]  C. Di Serio,et al.  Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation , 2012, Proceedings of the National Academy of Sciences.

[11]  I. Krägeloh-Mann,et al.  The natural course of gross motor deterioration in metachromatic leukodystrophy , 2011, Developmental medicine and child neurology.

[12]  W. Grodd,et al.  Metachromatic leukodystrophy: natural course of cerebral MRI changes in relation to clinical course , 2011, Journal of Inherited Metabolic Disease.

[13]  Gianluigi Zanetti,et al.  Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. , 2011, Blood.

[14]  L. Naldini,et al.  Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model. , 2010, Blood.

[15]  G. Comi,et al.  Foot Pad Skin Biopsy in Mouse Models of Hereditary Neuropathy , 2010, Glia.

[16]  Alessandra Biffi,et al.  Identification of Hematopoietic Stem Cell–Specific miRNAs Enables Gene Therapy of Globoid Cell Leukodystrophy , 2010, Science Translational Medicine.

[17]  Jérôme Larghero,et al.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia , 2010, Nature.

[18]  I. Krägeloh-Mann,et al.  Metachromatic Leukodystrophy – An Update , 2010, Neuropediatrics.

[19]  Manfred Schmidt,et al.  Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy , 2009, Science.

[20]  M. Falautano,et al.  Metachromatic leukodystrophy – mutation analysis provides further evidence of genotype–phenotype correlation , 2008, Clinical genetics.

[21]  L. Naldini,et al.  Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice. , 2006, The Journal of clinical investigation.

[22]  David Bryder,et al.  Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. , 2006, The American journal of pathology.

[23]  L. Naldini,et al.  Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. , 2004, The Journal of clinical investigation.

[24]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[25]  D. Bates,et al.  Mixed-Effects Models in S and S-PLUS , 2001 .

[26]  Jesús Calleja,et al.  Peripheral motor and sensory nerve conduction studies in normal infants and children , 2000, Clinical Neurophysiology.

[27]  G. Comi,et al.  Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas , 1997, Diabetologia.

[28]  R. Lovelace,et al.  Electrophysiologic Correlates of Peripheral Nervous System Maturation in Infancy and Childhood , 1993, Journal of child neurology.

[29]  Sattar Alshryda,et al.  Development and Reliability of a System to Classify Gross Motor Function in Children with Cerebral Palsy , 2014 .

[30]  J. Tolar,et al.  Transplant outcomes in leukodystrophies. , 2010, Seminars in hematology.